124 related articles for article (PubMed ID: 10354960)
1. Nortriptyline E-10-hydroxylation in vitro is mediated by human CYP2D6 (high affinity) and CYP3A4 (low affinity): implications for interactions with enzyme-inducing drugs.
Venkatakrishnan K; von Moltke LL; Greenblatt DJ
J Clin Pharmacol; 1999 Jun; 39(6):567-77. PubMed ID: 10354960
[TBL] [Abstract][Full Text] [Related]
2. Contribution of human cytochrome p-450 isoforms to the metabolism of the simplest phenothiazine neuroleptic promazine.
Wójcikowski J; Pichard-Garcia L; Maurel P; Daniel WA
Br J Pharmacol; 2003 Apr; 138(8):1465-74. PubMed ID: 12721102
[TBL] [Abstract][Full Text] [Related]
3. CYP2D6 and CYP3A4 involvement in the primary oxidative metabolism of hydrocodone by human liver microsomes.
Hutchinson MR; Menelaou A; Foster DJ; Coller JK; Somogyi AA
Br J Clin Pharmacol; 2004 Mar; 57(3):287-97. PubMed ID: 14998425
[TBL] [Abstract][Full Text] [Related]
4. Metabolism of Benzalkonium Chlorides by Human Hepatic Cytochromes P450.
Seguin RP; Herron JM; Lopez VA; Dempsey JL; Xu L
Chem Res Toxicol; 2019 Dec; 32(12):2466-2478. PubMed ID: 31730751
[TBL] [Abstract][Full Text] [Related]
5. Involvement of multiple human cytochromes P450 in the liver microsomal metabolism of astemizole and a comparison with terfenadine.
Matsumoto S; Yamazoe Y
Br J Clin Pharmacol; 2001 Feb; 51(2):133-42. PubMed ID: 11259984
[TBL] [Abstract][Full Text] [Related]
6. Inhibition Effect of Okanin Toward Human Cytochrome P450 3A4 and 2D6 with Multi-spectroscopic Studies and Molecular Docking.
Wang S; Wang M; Cui J; Lian D; Li L
J Fluoresc; 2024 Jan; 34(1):203-212. PubMed ID: 37191827
[TBL] [Abstract][Full Text] [Related]
7. Rehmannioside A inhibits the activity of CYP3A4, 2C9 and 2D6 in vitro.
Wang C; Zhou N; Li M; Chen H
Xenobiotica; 2024 Apr; 54(4):195-200. PubMed ID: 38385556
[TBL] [Abstract][Full Text] [Related]
8. The Respective Roles of CYP3A4 and CYP2D6 in the Metabolism of Pimozide to Established and Novel Metabolites.
Chapron BD; Dinh JC; Toren PC; Gaedigk A; Leeder JS
Drug Metab Dispos; 2020 Nov; 48(11):1113-1120. PubMed ID: 32847865
[TBL] [Abstract][Full Text] [Related]
9. Effect of tubeimoside I on the activity of cytochrome P450 enzymes in human liver microsomes.
Wang R; Zheng K; Liu Y; Ji S; Tang Y; Wang J; Jiang R
Xenobiotica; 2024 Feb; 54(2):57-63. PubMed ID: 38166553
[TBL] [Abstract][Full Text] [Related]
10. An improved substrate cocktail for assessing direct inhibition and time-dependent inhibition of multiple cytochrome P450s.
Chen ZH; Zhang SX; Long N; Lin LS; Chen T; Zhang FP; Lv XQ; Ye PZ; Li N; Zhang KZ
Acta Pharmacol Sin; 2016 May; 37(5):708-18. PubMed ID: 27063220
[TBL] [Abstract][Full Text] [Related]
11. Time-dependent inhibition of human drug metabolizing cytochromes P450 by tricyclic antidepressants.
Polasek TM; Miners JO
Br J Clin Pharmacol; 2008 Jan; 65(1):87-97. PubMed ID: 17662092
[TBL] [Abstract][Full Text] [Related]
12. Evidence of impaired cisapride metabolism in neonates.
Tréluyer JM; Rey E; Sonnier M; Pons G; Cresteil T
Br J Clin Pharmacol; 2001 Oct; 52(4):419-25. PubMed ID: 11678785
[TBL] [Abstract][Full Text] [Related]
13. The roles of CYP2C19 and CYP3A4 in the in vitro metabolism of β-eudesmol in human liver: Reaction phenotyping and enzyme kinetics.
Muhamad N; Na-Bangchang K
Pharmacol Res Perspect; 2023 Dec; 11(6):e01149. PubMed ID: 37902256
[TBL] [Abstract][Full Text] [Related]
14. Effect of eugenol on cytochrome P450 1A2, 2C9, 2D6, and 3A4 activity in human liver microsomes.
Alharbi NFM; Ahad A; Bin Jardan YA; Al-Jenoobi FI
Saudi Pharm J; 2024 Jul; 32(7):102118. PubMed ID: 38841106
[TBL] [Abstract][Full Text] [Related]
15. Exploration of cytochrome P450 inhibition mediated drug-drug interaction potential of kratom alkaloids.
Kamble SH; Sharma A; King TI; Berthold EC; León F; Meyer PKL; Kanumuri SRR; McMahon LR; McCurdy CR; Avery BA
Toxicol Lett; 2020 Feb; 319():148-154. PubMed ID: 31707106
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo human metabolism and pharmacokinetics of S- and R-praziquantel.
Kapungu NN; Li X; Nhachi C; Masimirembwa C; Thelingwani RS
Pharmacol Res Perspect; 2020 Aug; 8(4):e00618. PubMed ID: 32700798
[TBL] [Abstract][Full Text] [Related]
17. Sertraline-induced potentiation of the CYP3A4-dependent neurotoxicity of carbamazepine: an in vitro study.
Ghosh C; Hossain M; Spriggs A; Ghosh A; Grant GA; Marchi N; Perucca E; Janigro D
Epilepsia; 2015 Mar; 56(3):439-49. PubMed ID: 25656284
[TBL] [Abstract][Full Text] [Related]
18. Estimation of the binding modes with important human cytochrome P450 enzymes, drug interaction potential, pharmacokinetics, and hepatotoxicity of ginger components using molecular docking, computational, and pharmacokinetic modeling studies.
Qiu JX; Zhou ZW; He ZX; Zhang X; Zhou SF; Zhu S
Drug Des Devel Ther; 2015; 9():841-66. PubMed ID: 25733806
[TBL] [Abstract][Full Text] [Related]
19. Induction of hepatic CYP3A4 expression by cholesterol and cholic acid: Alterations of gene expression, microsomal activity, and pharmacokinetics.
Minegishi G; Kobayashi Y; Fujikura M; Sano A; Kazuki Y; Kobayashi K
Pharmacol Res Perspect; 2024 Jun; 12(3):e1197. PubMed ID: 38644590
[TBL] [Abstract][Full Text] [Related]
20. Water Exchange from the Buried Binding Sites of Cytochrome P450 Enzymes 1A2, 2D6, and 3A4 Correlates with Conformational Fluctuations.
Guvench O
Molecules; 2024 Jan; 29(2):. PubMed ID: 38276571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
